Exogenous nerve growth factor promotes the repair of cardiac sympathetic heterogeneity and electrophysiological instability in diabetic rats

Cardiology (Switzerland)

Volumn 127, Issue 3, 2014, Pages 155-163

  Xue, Mei ^a,b   Xuan, Yong Li ^a   Wang, Ye ^b   Hu, He Sheng ^b   Li, Xiao Lu ^b   Suo, Fei ^b   Li, Xin Ran ^a   Cheng, Wen Juan ^b   Yan, Su Hua ^b  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac sympathetic innervation; Diabetes mellitus; Nerve growth factor; Ventricular arrhythmias

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; MESSENGER RNA; NERVE GROWTH FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NEUROPATHY; CARDIAC AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEMOGLOBIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LEFT STELLATE GANGLION; MALE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QT PROLONGATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE GANGLION; SYMPATHETIC INNERVATION; WESTERN BLOTTING; CELL DENSITY; ELECTROPHYSIOLOGICAL PROCEDURES; SYMPATHETIC HETEROGENEITY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ELECTRIC STIMULATION; MALE; NERVE GROWTH FACTOR; RANDOM ALLOCATION; RATS, WISTAR; RNA, MESSENGER;

EID: 84896113181     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000355535     Document Type: Article

References (35)

1. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P: Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011, E-pub ahead of print
2. Ieda M, Fukuda K: New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: The regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance. J Pharmacol Sci 2009; 109: 348-353
3. Schmid H, Forman LA, Cao X, Sherman PS, Stevens MJ: Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: Implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes 1999; 48: 603-608
4. Karayannis G, Giamouzis G, Cokkinos DV, Skoularigis J, Triposkiadis F: Diabetic cardiovascular autonomic neuropathy: Clinical implications. Expert Rev Cardiovasc Ther 2012; 10: 747-765
5. Vujosevic S, Zamaklar M, Belada N, Stamatovic S: Mortality after acute myocardial infarction: Significance of cardiovascular diabetic autonomic neuropathy (CDAN). Med Arh 2012; 66: 296-299
6. Jermendy G: Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol 2003; 40(suppl 2): S370-S374
7. Siscovick DS, Sotoodehnia N, Rea TD, Raghunathan TE, Jouven X, Lemaitre RN: Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord 2010; 11: 53-59
8. Ziegler D: Diabetic autonomic neuropathy. Cardiac sympathetic 'dysinnervation,' QT interval prolongation, and mortality. Clin Auton Res 2002; 12: 349-352
9. Wang Y, Xuan YL, Hu HS, Li XL, Xue M, Cheng WJ, Suo F, Yan SH: Risk of ventricular arrhythmias after myocardial infarction with diabetes associated with sympathetic neural remodeling in rabbits. Cardiology 2012; 121: 1-9
10. Yan SH, Hu HS, Wang LX, Xing QC, Cheng WJ, Xue M: Effects of angiotensin converting enzyme inhibition on cardiac innervation and ventricular arrhythmias after myocardial infarction. Clin Invest Med 2008; 31:E198-E205
11. Yan SH, Hu HS, Wang XL, Xing QC, Wang Q, Shi CW, Cheng WJ, Xue M: Effects of prolonged metoprolol treatment on neural remodeling and inducible ventricular arrhythmias after myocardial infarction in rabbits. Int J Cardiol 2007; 117: 317-322
12. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen PS: Nerve sprouting and sudden cardiac death. Circ Res 2000; 86: 816-821
13. Zola B, Kahn JK, Juni JE, Vinik AI: Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab 1986; 63: 208-214
14. Schwartz PJ, Verrier RL, Lown B: Effect of stellectomy and vagotomy on ventricular refractoriness in dogs. Circ Res 1977; 40: 536-540
15. Bergado JA, Fernandez CI, Gomez-Soria A, Gonzalez O: Chronic intraventricular infusion with NGF improves LTP in old cognitively-impaired rats. Brain Res 1997; 770: 1-9
16. Abdi S, Yang Z: A novel technique for experimental stellate ganglion block in rats. Anesth Analg 2005; 101: 561-565
17. Kang CS, Chen CC, Lin CC, Chang NC, Lee TM: Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts. Am J Physiol Heart Circ Physiol 2009; 296:H1949-H1959
18. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen PS, Chen LS: Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101: 1960-1969
19. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(t)) method. Methods 2001; 25: 402-408
20. Vaseghi M, Shivkumar K: The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis 2008; 50: 404-419
21. Rubart M, Zipes DP: Mechanisms of sudden cardiac death. J Clin Invest 2005; 115: 2305-2315
22. Chen LS, Zhou S, Fishbein MC, Chen PS: New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007; 18: 123-127
23. Qu J, Robinson RB: Cardiac ion channel expression and regulation: The role of innervation. J Mol Cell Cardiol 2004; 37: 439-448
24. Mahmoud KD, de Smet BJ, Zijlstra F, Rihal CS, Holmes DR Jr: Sudden cardiac death: Epidemiology, circadian variation, and triggers. Curr Probl Cardiol 2011; 36: 56-80
25. Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D, Yamada E, Raffel DM, Stevens MJ: Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004; 44: 2368-2374
26. Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB, Hilsted J: Left ventricular dysfunction in normotensive type 1 diabetic patients: The impact of autonomic neuropathy. Diabet Med 2004; 21: 524-530
27. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M: Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk. Circulation 1998; 98: 961-968
28. Vinik AI, Erbas T, Casellini CM: Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig 2013; 4: 4-18
29. Odusan O, Familoni OB, Raimi TH: Correlates of cardiac autonomic neuropathy in Nigerian patients with type 2 diabetes mellitus. Afr J Med Med Sci 2008; 37: 315-320
30. Khandoker AH, Imam MH, Couderc JP, Palaniswami M, Jelinek HF: QT variability index changes with severity of cardiovascular autonomic neuropathy. IEEE Trans Inf Technol Biomed 2012; 16: 900-906
31. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-397
32. Lockhart ST, Turrigiano GG, Birren SJ: Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci 1997; 17: 9573-9582
33. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412
34. Naveilhan P, Neveu I, Jehan F, Baudet C, Wion D, Brachet P: Reactive oxygen species influence nerve growth factor synthesis in primary rat astrocytes. J Neurochem 1994; 62: 2178-2186
35. Meloni M, Descamps B, Caporali A, Zentilin L, Floris I, Giacca M, Emanueli C: Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes 2012; 61: 229-240